HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
RPR 130401
a farnesyltransferase inhibitor; structure in first source
Also Known As:
RPR-130401
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Indoles: 200
RPR 130401: 1
Experts
1.
Favaudon, Vincent
: 1 article (01/2002)
2.
Lavelle, François
: 1 article (01/2002)
3.
Mégnin-Chanet, Frédérique
: 1 article (01/2002)
Related Diseases
1.
Neoplasms (Cancer)
01/01/2002 - "
The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distribution.
"
Related Drugs and Biologics
1.
Lamin Type B (Lamin B)
2.
Transferases